The RANTES gene promoter polymorphisms are associated with the risk of atherothrombotic cerebral infarction in Northern Han Chinese

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 1112-1115

  Qin, Xue ^a   He, Zhiyi ^a   Zhao, Dongxue ^a   Li, Lei ^a   Yuan, Liying ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Atherothrombotic cerebral infarction (ACI); Normal T cell expressed and secreted (RANTES); Regulated upon activation; Single nucleotide polymorphism

Indexed keywords

RANTES;

ADULT; AGED; ARTICLE; ATHEROTHROMBOTIC CEREBRAL INFARCTION; BRAIN INFARCTION; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHEMOKINE CCL5; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 79955034366     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.02.033     Document Type: Article

References (32)

1. Johnston S.C., Mendis S., Mathers C.D. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009, 8:345-354.
2. Goldstein L.B., Adams R., Becker K., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001, 103:163-182.
3. Cushman M., Cantrell R.A., McClure L.A., et al. Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol 2008, 64:507-513.
4. Gretarsdottir S., Thorleifsson G., Manolescu A., et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 2008, 64:402-409.
5. Ikram M.A., Seshadri S., Bis J.C., et al. Genomewide association studies of stroke. N Engl J Med 2009, 360:1718-1728.
6. Braunersreuther V., Mach F., Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost 2007, 97:714-721.
7. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
8. Pattison J.M., Nelson P.J., Huie P., et al. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant 1996, 15:1194-1199.
9. Parissis J.T., Adamopoulos S., Venetsanou K.F., et al. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. J Interferon Cytokine Res 2002, 22:223-229.
10. von Hundelshausen P., Weber K.S., Huo Y., et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001, 103:1772-1777.
11. Veillard N.R., Kwak B., Pelli G., et al. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 2004, 94:253-261.
12. An P., Nelson G.W., Wang L., et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002, 99:10002-10007.
13. McDermott D.H., Beecroft M.J., Kleeberger C.A., et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 2000, 14:2671-2678.
14. Nickel R.G., Casolaro V., Wahn U., et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000, 164:1612-1616.
15. Simeoni E., Winkelmann B.R., Hoffmann M.M., et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 2004, 25:1438-1446.
16. Vogiatzi K., Voudris V., Apostolakis S., et al. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention. Thromb Res 2009, 124:84-89.
17. Ghilardi G., Biondi M.L., Turri O., et al. Genetic control of chemokines in severe human internal carotid artery stenosis. Cytokine 2008, 41:24-28.
18. Um J.Y., Kim H.M. Polymorphisms of RANTES and IL-4 genes in cerebral infarction. J Mol Neurosci 2009, 37:1-5.
19. Yamaguchi S., Yamada Y., Metoki N., et al. Genetic risk for atherothrombotic cerebral infarction in individuals stratified by sex or conventional risk factors for atherosclerosis. Int J Mol Med 2006, 18:871-883.
20. Jang Y., Chae J.S., Hyun Y.J., et al. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease. Clin Sci lond 2007, 113:349-356.
21. Palomäki H., Kaste M. Regular light-to-moderate intake of alcohol and the risk of ischemic stroke. Is there a beneficial effect?. Stroke 1993, 24:1828-1832.
22. Li Z., Zhang Z., He Z., et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res 2009, 19:519-523. http://analysis.bio-x.cn.
23. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
24. Fryer A.A., Spiteri M.A., Bianco A., et al. The -403G->A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 2000, 1:509-514.
25. Liu H., Chao D., Nakayama E.E., et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999, 96:4581-4585.
26. Nakajima K., Tanaka Y., Nomiyama T., et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diab Care 2003, 26:892-898.
27. Terkeltaub R., Boisvert W.A., Curtiss L.K. Chemokines and atherosclerosis. Curr Opin Lipidol 1998, 9:397-405.
28. Breland U.M., Michelsen A.E., Skjelland M., et al. Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovasc Res 2010, 86:265-273.
29. Cavusoglu E., Eng C., Chopra V., et al. Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography. Arterioscler Thromb Vasc Biol 2007, 27:929-935.
30. Rothenbacher D., Müller-Scholze S., Herder C., et al. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 2006, 26:194-199.
31. Makino Y., Cook D.N., Smithies O., et al. Impaired T cell function in RANTES-deficient mice. Clin Immunol 2002, 102:302-309.
32. Weyrich A.S., Elstad M.R., McEver R.P., et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996, 97:1525-1534.